BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25159293)

  • 1. Telomere length and mortality following a diagnosis of ovarian cancer.
    Kotsopoulos J; Prescott J; De Vivo I; Fan I; Mclaughlin J; Rosen B; Risch H; Sun P; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2603-6. PubMed ID: 25159293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediagnosis Leukocyte Telomere Length and Risk of Ovarian Cancer.
    Yang M; Prescott J; Poole EM; Rice MS; Kubzansky LD; Idahl A; Lundin E; De Vivo I; Tworoger SS
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):339-345. PubMed ID: 28209595
    [No Abstract]   [Full Text] [Related]  

  • 3. Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases.
    Martinez-Delgado B; Yanowsky K; Inglada-Perez L; de la Hoya M; Caldes T; Vega A; Blanco A; Martin T; Gonzalez-Sarmiento R; Blasco M; Robledo M; Urioste M; Song H; Pharoah P; Benitez J
    J Med Genet; 2012 May; 49(5):341-4. PubMed ID: 22493152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shorter leukocyte telomere length is independently associated with poor survival in patients with bladder cancer.
    Russo A; Modica F; Guarrera S; Fiorito G; Pardini B; Viberti C; Allione A; Critelli R; Bosio A; Casetta G; Cucchiarale G; Destefanis P; Gontero P; Rolle L; Zitella A; Fontana D; Frea B; Vineis P; Sacerdote C; Matullo G
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2439-46. PubMed ID: 25234236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between prediagnostic leukocyte telomere length and breast cancer risk: the Singapore Chinese Health Study.
    Samavat H; Xun X; Jin A; Wang R; Koh WP; Yuan JM
    Breast Cancer Res; 2019 Apr; 21(1):50. PubMed ID: 30995937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in peripheral blood leukocyte telomere length and mortality in breast cancer survivors.
    Duggan C; Risques R; Alfano C; Prunkard D; Imayama I; Holte S; Baumgartner K; Baumgartner R; Bernstein L; Ballard-Barbash R; Rabinovitch P; McTiernan A
    J Natl Cancer Inst; 2014 Apr; 106(4):dju035. PubMed ID: 24627273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte telomere length and renal cell carcinoma survival in two studies.
    Callahan CL; Schwartz K; Ruterbusch JJ; Shuch B; Graubard BI; Lan Q; Cawthon R; Baccarelli AA; Chow WH; Rothman N; Hofmann JN; Purdue MP
    Br J Cancer; 2017 Aug; 117(5):752-755. PubMed ID: 28742796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between leukocyte telomere length and the risk of pancreatic cancer: Findings from a prospective study.
    Luu HN; Huang JY; Wang R; Adams-Haduch J; Jin A; Koh WP; Yuan JM
    PLoS One; 2019; 14(8):e0221697. PubMed ID: 31465482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study.
    Mirabello L; Garcia-Closas M; Cawthon R; Lissowska J; Brinton LA; Pepłońska B; Sherman ME; Savage SA
    Cancer Causes Control; 2010 Jan; 21(1):77-82. PubMed ID: 19784860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk.
    Terry KL; Tworoger SS; Vitonis AF; Wong J; Titus-Ernstoff L; De Vivo I; Cramer DW
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):504-12. PubMed ID: 22267287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early telomere shortening and genomic instability in tubo-ovarian preneoplastic lesions.
    Chene G; Tchirkov A; Pierre-Eymard E; Dauplat J; Raoelfils I; Cayre A; Watkin E; Vago P; Penault-Llorca F
    Clin Cancer Res; 2013 Jun; 19(11):2873-82. PubMed ID: 23589176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere length and pancreatic cancer: a case-control study.
    Skinner HG; Gangnon RE; Litzelman K; Johnson RA; Chari ST; Petersen GM; Boardman LA
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2095-100. PubMed ID: 23093543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte telomere length, cancer incidence and all-cause mortality among Chinese adults: Singapore Chinese Health Study.
    Samavat H; Luu HN; Beckman KB; Jin A; Wang R; Koh WP; Yuan JM
    Int J Cancer; 2021 Jan; 148(2):352-362. PubMed ID: 33459354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short leukocyte telomere length, alone and in combination with smoking, contributes to increased risk of gastric cancer or esophageal squamous cell carcinoma.
    Pan W; Du J; Shi M; Jin G; Yang M
    Carcinogenesis; 2017 Jan; 38(1):12-18. PubMed ID: 27797826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative telomere length and prostate cancer mortality.
    Renner W; Krenn-Pilko S; Gruber HJ; Herrmann M; Langsenlehner T
    Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):579-583. PubMed ID: 30082901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: data from the Heart and Soul Study.
    Farzaneh-Far R; Cawthon RM; Na B; Browner WS; Schiller NB; Whooley MA
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1379-84. PubMed ID: 18467646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis.
    Kuhn E; Meeker A; Wang TL; Sehdev AS; Kurman RJ; Shih IeM
    Am J Surg Pathol; 2010 Jun; 34(6):829-36. PubMed ID: 20431479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short telomere length, cancer survival, and cancer risk in 47102 individuals.
    Weischer M; Nordestgaard BG; Cawthon RM; Freiberg JJ; Tybjærg-Hansen A; Bojesen SE
    J Natl Cancer Inst; 2013 Apr; 105(7):459-68. PubMed ID: 23468462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere length and risk of incident cancer and cancer mortality.
    Willeit P; Willeit J; Mayr A; Weger S; Oberhollenzer F; Brandstätter A; Kronenberg F; Kiechl S
    JAMA; 2010 Jul; 304(1):69-75. PubMed ID: 20606151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Bao D; Ba Y; Zhou F; Zhao J; Yang Q; Ge N; Guo X; Wu Z; Zhang H; Yang H; Wan S; Xing J
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):791-9. PubMed ID: 27558242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.